Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion type Assertion NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_head.
- NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion description "[In serous carcinoma, patients with CYP1A1 Ile/Val and Val/Val revealed a 6.5- and 10-fold higher risk of having ovarian cancer (OR 7.09, 95% CI 3.30-15.22; and OR 8.77, 95% CI 2.83-27.14).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_provenance.
- NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion evidence source_evidence_literature NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_provenance.
- NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion SIO_000772 12144816 NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_provenance.
- NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion wasDerivedFrom befree-20140225 NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_provenance.
- NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_assertion wasGeneratedBy ECO_0000203 NP783143.RAEpFg-hh0ROJa3RiJiMMQhnmQLywPZm44cRMUAO7weyk130_provenance.